• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

April 17, 2020

View Archived Issues
Coronavirus vs US

Administration’s outpatient-first policy should aid cardiovascular, orthopedic implants

The Trump administration has proposed a policy to gradually reopen the U.S. for business, part of which is to allow a resumption of elective procedures and treatments in outpatient settings. While patients with urgent medical needs presumably are being treated already, the policy would seem to promise a boost in volumes for certain devices, such as coronary artery stents, knee implants and transcatheter aortic valve replacement (TAVR) devices, all of which enjoy at least limited Medicare coverage for outpatient use. Read More
4-17-intuitive-da-vinci.png

Intuitive climbs on earnings, but cautious on growth in procedures, hospital sales

Robotic-assisted surgical procedures have fallen off steeply as the ongoing global pandemic has unfolded, but the real impact on Intuitive Surgical Inc. will come as its hospital customers may have to limit orders for expensive equipment upgrades as they struggle to manage unprecedented financial burdens. The U.S. accounts for about 70% of its robotic surgery procedures, but by the last few weeks in March, that activity had been curtailed by roughly two-thirds. Read More
Asia-Pakistan-flag-map.png

Pakistan taps into tech to spread pharma info, limit counterfeits

KARACHI, Pakistan – The government of Pakistan is tapping into mobile technology to protect its pharmaceutical supply chain and prevent abuse. As part of an ongoing effort to deal with an overabundance of fake and counterfeit medicines, Pakistan has introduced a mobile app that allows for instant access to the country’s National Essential Medicines List (NEML) while giving patients access to drug information and the ability to lodge complaints with regulators. Read More
4-17-AFCROs-president-Comet.png

France in pole position for clinical research with medical devices in Europe

PARIS – The French Association of CROs (AFCROs) has published the third edition of its survey of clinical research in France. This tool is intended to provide an overview of clinical research in that country, along with any recent developments. Read More
Keith-Ligon,-MD,-PhD-Credit-Dana-Farber-Cancer-Institute 4-15

For gliomas, hypermutated does not mean sensitive to checkpoint blockade

The largest study to date on hypermutated gliomas has delivered new insights into their origin, as well as their response to several different treatments. Specifically, even though they are hypermutated, such tumors are unlikely to respond to PD-1 blockers. Read More

Appointments and advancements for April 17, 2020

New hires and promotions in the med-tech industry, including: Clearpoint Neuro, Haemonetics, Lexington Biosciences, Todos Medical. Read More

Financings for April 17, 2020

Med-tech firms raising money in public or private financings, including: Cutera, Inspire Medical Systems, In Vivo Therapeutics, Medx Health. Read More

In the clinic for April 17, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Nexstim. Read More

Med-tech gainers and losers for April 13-17, 2020

The top 10 med-tech stock gainers and losers for the week. Read More

Other news to note for April 17, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Applied Biosystems, Assistek, Chronically Simple, Debiotech, Genetic Technologies, Gold Standard Diagnostics Group, Inform Diagnostics, Intelligent Fingerprinting, Kraig Biocraft, Masimo, Medmira, Promega, Qventus, Roche, Rxmx, Samsung, Sanvello, True Diagnostics, Veracyte, Veravas. Read More

Regulatory front for April 17, 2020

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: J1 Medical. Read More

BioWorld MedTech’s Neurology Extra for April 17, 2020

Keeping you up to date on recent developments in neurology, including: Gene variant may protect against Alzheimer's; Miniature microscope used to study neural circuit activity in nonhuman primate model; Dopamine has epigenetic role in addiction; Depression’s structural problem. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 22, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 22, 2025.
  • HIV virus cells

    Coinfections and diversity paint the many shades of HIV cure

    BioWorld
    We all look different to HIV, a virus that destroys the immune system. The defensive cells record every interaction with foreign agents, infections from viruses...
  • Skin irritation on hands

    Livzon’s IL-17A/F meets phase III endpoints in plaque psoriasis ​

    BioWorld
    Livzon Mabpharm Inc.’s anti-IL-17A/F monoclonal antibody, LZM-012, met the primary endpoint in a phase III trial in moderate to severe plaque psoriasis. Conducted...
  • Sino to acquire Lanova and pipeline for up to $950M

    BioWorld Asia
    Sino Biopharmaceutical Ltd. agreed to fully acquire Lanova Medicines Ltd. by buying an additional 95.09% stake in Lanova at a valuation of up to $950.92 million....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe